Global Granulocyte Macrophage Colony Stimulating Factor Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The Granulocyte Macrophage Colony Stimulating Factor Market is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of XX.0% during the forecast period. The research provides insights for the global Granulocyte Macrophage Colony Stimulating Factor market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Granulocyte Macrophage Colony Stimulating Factor industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Global Granulocyte Macrophage Colony Stimulating Factor Market Segmentations:

    By Players:

    • Mologen AG

    • Aduro BioTech Inc

    • BriaCell Therapeutics Corp

    • Sillajen Biotherapeutics

    • Cold Genesys Inc

    • Humanigen Inc

    • Morphotek Inc

    • Amgen Inc

    • GlaxoSmithKline Plc

    • Takeda Pharmaceutical Co Ltd

    By Types:

    • CG-0070

    • Gimsilumab

    • GSK-3196165

    • Lenzilumab

    • MGN-1601

    • Others

    By End-User:

    • Solid Tumor

    • Lymphoma

    • Kidney Cancer

    • Lung Disease

    • Others

    By Regions:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Granulocyte Macrophage Colony Stimulating Factor Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of CG-0070 from 2014 to 2026

      • 1.3.2 Global Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Gimsilumab from 2014 to 2026

      • 1.3.3 Global Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of GSK-3196165 from 2014 to 2026

      • 1.3.4 Global Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Lenzilumab from 2014 to 2026

      • 1.3.5 Global Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of MGN-1601 from 2014 to 2026

      • 1.3.6 Global Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Solid Tumor from 2014 to 2026

      • 1.4.2 Global Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Lymphoma from 2014 to 2026

      • 1.4.3 Global Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Kidney Cancer from 2014 to 2026

      • 1.4.4 Global Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Lung Disease from 2014 to 2026

      • 1.4.5 Global Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 Belgium Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Granulocyte Macrophage Colony Stimulating Factor Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Granulocyte Macrophage Colony Stimulating Factor by Major Types

      • 3.4.1 Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of CG-0070

      • 3.4.2 Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Gimsilumab

      • 3.4.3 Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of GSK-3196165

      • 3.4.4 Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Lenzilumab

      • 3.4.5 Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of MGN-1601

      • 3.4.6 Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Others

    4 Segmentation of Granulocyte Macrophage Colony Stimulating Factor Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Granulocyte Macrophage Colony Stimulating Factor by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Granulocyte Macrophage Colony Stimulating Factor in Solid Tumor

      • 4.4.2 Market Size and Growth Rate of Granulocyte Macrophage Colony Stimulating Factor in Lymphoma

      • 4.4.3 Market Size and Growth Rate of Granulocyte Macrophage Colony Stimulating Factor in Kidney Cancer

      • 4.4.4 Market Size and Growth Rate of Granulocyte Macrophage Colony Stimulating Factor in Lung Disease

      • 4.4.5 Market Size and Growth Rate of Granulocyte Macrophage Colony Stimulating Factor in Others

    5 Market Analysis by Major Regions

    • 5.1 Global Granulocyte Macrophage Colony Stimulating Factor Production Analysis by Major Regions

    • 5.2 Global Granulocyte Macrophage Colony Stimulating Factor Consumption Analysis by Major Regions

    • 5.3 Global Granulocyte Macrophage Colony Stimulating Factor Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Granulocyte Macrophage Colony Stimulating Factor Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Granulocyte Macrophage Colony Stimulating Factor Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Production, Import, Consumption and Export Analysis

    6 Product Commodity of Granulocyte Macrophage Colony Stimulating Factor Market in Major Countries

    • 6.1 Top 5 Export Countries in Granulocyte Macrophage Colony Stimulating Factor market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Granulocyte Macrophage Colony Stimulating Factor market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Granulocyte Macrophage Colony Stimulating Factor market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Granulocyte Macrophage Colony Stimulating Factor market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Granulocyte Macrophage Colony Stimulating Factor market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Granulocyte Macrophage Colony Stimulating Factor market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7 North America Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis

    • 7.1 North America Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis by Major Types

    • 7.2 North America Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis by Major End-Users

    • 7.3 North America Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis by Major Countries

      • 7.3.1 United States Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate

      • 7.3.2 Canada Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate

      • 7.3.3 Mexico Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate

    8 Europe Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis

    • 8.1 Europe Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis by Major Types

    • 8.2 Europe Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis by Major End-Users

    • 8.3 Europe Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis by Major Countries

      • 8.3.1 Germany Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate

      • 8.3.2 UK Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate

      • 8.3.3 France Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate

      • 8.3.4 Italy Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate

      • 8.3.6 Spain Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate

      • 8.3.7 Belgium Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate

      • 8.3.8 Poland Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate

      • 8.3.9 Russia Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate

      • 8.3.10 Turkey Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate

    9 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis

    • 9.1 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis by Major Types

    • 9.2 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis by Major Countries

      • 9.3.1 China Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate

      • 9.3.2 Japan Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate

      • 9.3.4 India Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate

      • 9.3.6 South Korea Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate

    10 Latin America, Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate

      • 10.3.2 Brazil Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate

      • 10.3.3 Nigeria Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate

      • 10.3.4 South Africa Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate 

      • 10.3.5 Argentina Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate

    11 Major Players Profile

    • 11.1 Mologen AG

      • 11.1.1 Mologen AG Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Aduro BioTech Inc

      • 11.2.1 Aduro BioTech Inc Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 BriaCell Therapeutics Corp

      • 11.3.1 BriaCell Therapeutics Corp Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Sillajen Biotherapeutics

      • 11.4.1 Sillajen Biotherapeutics Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Cold Genesys Inc

      • 11.5.1 Cold Genesys Inc Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Humanigen Inc

      • 11.6.1 Humanigen Inc Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Morphotek Inc

      • 11.7.1 Morphotek Inc Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Amgen Inc

      • 11.8.1 Amgen Inc Company Profile and Recent Development

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 GlaxoSmithKline Plc

      • 11.9.1 GlaxoSmithKline Plc Company Profile and Recent Development

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 Takeda Pharmaceutical Co Ltd

      • 11.10.1 Takeda Pharmaceutical Co Ltd Company Profile and Recent Development

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

    12 Data Source and Research Methodology

    The List of Tables and Figures (Totals 104 Figures and 203 Tables)

    • Figure Product Picture

    • Figure Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of CG-0070 from 2014 to 2026

    • Figure Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Gimsilumab from 2014 to 2026

    • Figure Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of GSK-3196165 from 2014 to 2026

    • Figure Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Lenzilumab from 2014 to 2026

    • Figure Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of MGN-1601 from 2014 to 2026

    • Figure Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Solid Tumor from 2014 to 2026

    • Figure Global Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Lymphoma from 2014 to 2026

    • Figure Global Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Kidney Cancer from 2014 to 2026

    • Figure Global Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Lung Disease from 2014 to 2026

    • Figure Global Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America Granulocyte Macrophage Colony Stimulating Factor Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States Granulocyte Macrophage Colony Stimulating Factor Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Granulocyte Macrophage Colony Stimulating Factor Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Granulocyte Macrophage Colony Stimulating Factor Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Granulocyte Macrophage Colony Stimulating Factor Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Granulocyte Macrophage Colony Stimulating Factor Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK Granulocyte Macrophage Colony Stimulating Factor Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France Granulocyte Macrophage Colony Stimulating Factor Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Granulocyte Macrophage Colony Stimulating Factor Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Granulocyte Macrophage Colony Stimulating Factor Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Granulocyte Macrophage Colony Stimulating Factor Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Granulocyte Macrophage Colony Stimulating Factor Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Granulocyte Macrophage Colony Stimulating Factor Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Granulocyte Macrophage Colony Stimulating Factor Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Granulocyte Macrophage Colony Stimulating Factor Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China Granulocyte Macrophage Colony Stimulating Factor Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Granulocyte Macrophage Colony Stimulating Factor Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand Granulocyte Macrophage Colony Stimulating Factor Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India Granulocyte Macrophage Colony Stimulating Factor Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Granulocyte Macrophage Colony Stimulating Factor Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Granulocyte Macrophage Colony Stimulating Factor Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries Granulocyte Macrophage Colony Stimulating Factor Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Granulocyte Macrophage Colony Stimulating Factor Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria Granulocyte Macrophage Colony Stimulating Factor Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Granulocyte Macrophage Colony Stimulating Factor Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Granulocyte Macrophage Colony Stimulating Factor Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Granulocyte Macrophage Colony Stimulating Factor Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Granulocyte Macrophage Colony Stimulating Factor

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Granulocyte Macrophage Colony Stimulating Factor by Different Types from 2014 to 2026

    • Table Consumption Share of Granulocyte Macrophage Colony Stimulating Factor by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of CG-0070

    • Figure Market Size and Growth Rate of Gimsilumab

    • Figure Market Size and Growth Rate of GSK-3196165

    • Figure Market Size and Growth Rate of Lenzilumab

    • Figure Market Size and Growth Rate of MGN-1601

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Granulocyte Macrophage Colony Stimulating Factor by Different End-Users from 2014 to 2026

    • Table Consumption Share of Granulocyte Macrophage Colony Stimulating Factor by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Solid Tumor

    • Figure Market Size and Growth Rate of Lymphoma

    • Figure Market Size and Growth Rate of Kidney Cancer

    • Figure Market Size and Growth Rate of Lung Disease

    • Figure Market Size and Growth Rate of Others

    • Table Global Granulocyte Macrophage Colony Stimulating Factor Production by Major Regions

    • Table Global Granulocyte Macrophage Colony Stimulating Factor Production Share by Major Regions

    • Figure Global Granulocyte Macrophage Colony Stimulating Factor Production Share by Major Regions in 2014

    • Figure Global Granulocyte Macrophage Colony Stimulating Factor Production Share by Major Regions in 2018

    • Figure Global Granulocyte Macrophage Colony Stimulating Factor Production Share by Major Regions in 2026

    • Table Global Granulocyte Macrophage Colony Stimulating Factor Consumption by Major Regions

    • Table Global Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Major Regions

    • Figure Global Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Major Regions in 2014

    • Figure Global Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Major Regions in 2018

    • Figure Global Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Major Regions in 2026

    • Table North America Granulocyte Macrophage Colony Stimulating Factor Production, Import, Consumption and Export Analysis

    • Table Europe Granulocyte Macrophage Colony Stimulating Factor Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Granulocyte Macrophage Colony Stimulating Factor market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Granulocyte Macrophage Colony Stimulating Factor market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Granulocyte Macrophage Colony Stimulating Factor market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Granulocyte Macrophage Colony Stimulating Factor market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Granulocyte Macrophage Colony Stimulating Factor Consumption by Types from 2014 to 2026

    • Table North America Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Types from 2014 to 2026

    • Figure North America Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Types in 2014

    • Figure North America Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Types in 2018

    • Figure North America Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Types in 2026

    • Table North America Granulocyte Macrophage Colony Stimulating Factor Consumption by End-Users from 2014 to 2026

    • Table North America Granulocyte Macrophage Colony Stimulating Factor Consumption Share by End-Users from 2014 to 2026

    • Figure North America Granulocyte Macrophage Colony Stimulating Factor Consumption Share by End-Users in 2014

    • Figure North America Granulocyte Macrophage Colony Stimulating Factor Consumption Share by End-Users in 2018

    • Figure North America Granulocyte Macrophage Colony Stimulating Factor Consumption Share by End-Users in 2026

    • Table North America Granulocyte Macrophage Colony Stimulating Factor Consumption by Major Countries from 2014 to 2026

    • Table North America Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Major Countries in 2014

    • Figure North America Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Major Countries in 2018

    • Figure North America Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Major Countries in 2026

    • Figure United States Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Granulocyte Macrophage Colony Stimulating Factor Consumption by Types from 2014 to 2026

    • Table Europe Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Types from 2014 to 2026

    • Figure Europe Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Types in 2014

    • Figure Europe Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Types in 2018

    • Figure Europe Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Types in 2026

    • Table Europe Granulocyte Macrophage Colony Stimulating Factor Consumption by End-Users from 2014 to 2026

    • Table Europe Granulocyte Macrophage Colony Stimulating Factor Consumption Share by End-Users from 2014 to 2026

    • Figure Europe Granulocyte Macrophage Colony Stimulating Factor Consumption Share by End-Users in 2014

    • Figure Europe Granulocyte Macrophage Colony Stimulating Factor Consumption Share by End-Users in 2018

    • Figure Europe Granulocyte Macrophage Colony Stimulating Factor Consumption Share by End-Users in 2026

    • Table Europe Granulocyte Macrophage Colony Stimulating Factor Consumption by Major Countries from 2014 to 2026

    • Table Europe Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Major Countries in 2014

    • Figure Europe Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Major Countries in 2018

    • Figure Europe Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Major Countries in 2026

    • Figure Germany Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate from 2014 to 2026

    • Figure France Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Consumption by Types from 2014 to 2026

    • Table Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Types in 2014

    • Figure Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Types in 2018

    • Figure Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Types in 2026

    • Table Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Consumption Share by End-Users in 2014

    • Figure Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Consumption Share by End-Users in 2018

    • Figure Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Consumption Share by End-Users in 2026

    • Table Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Major Countries in 2014

    • Figure Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Major Countries in 2026

    • Figure China Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandGranulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate from 2014 to 2026

    • Figure India Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Major Countries in 2026

    • Figure GCC Countries Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Mologen AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mologen AG

    • Figure Sales and Growth Rate Analysis of Mologen AG

    • Figure Revenue and Market Share Analysis of Mologen AG

    • Table Product and Service Introduction of Mologen AG

    • Table Company Profile and Development Status of Aduro BioTech Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aduro BioTech Inc

    • Figure Sales and Growth Rate Analysis of Aduro BioTech Inc

    • Figure Revenue and Market Share Analysis of Aduro BioTech Inc

    • Table Product and Service Introduction of Aduro BioTech Inc

    • Table Company Profile and Development Status of BriaCell Therapeutics Corp

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BriaCell Therapeutics Corp

    • Figure Sales and Growth Rate Analysis of BriaCell Therapeutics Corp

    • Figure Revenue and Market Share Analysis of BriaCell Therapeutics Corp

    • Table Product and Service Introduction of BriaCell Therapeutics Corp

    • Table Company Profile and Development Status of Sillajen Biotherapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sillajen Biotherapeutics

    • Figure Sales and Growth Rate Analysis of Sillajen Biotherapeutics

    • Figure Revenue and Market Share Analysis of Sillajen Biotherapeutics

    • Table Product and Service Introduction of Sillajen Biotherapeutics

    • Table Company Profile and Development Status of Cold Genesys Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cold Genesys Inc

    • Figure Sales and Growth Rate Analysis of Cold Genesys Inc

    • Figure Revenue and Market Share Analysis of Cold Genesys Inc

    • Table Product and Service Introduction of Cold Genesys Inc

    • Table Company Profile and Development Status of Humanigen Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Humanigen Inc

    • Figure Sales and Growth Rate Analysis of Humanigen Inc

    • Figure Revenue and Market Share Analysis of Humanigen Inc

    • Table Product and Service Introduction of Humanigen Inc

    • Table Company Profile and Development Status of Morphotek Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Morphotek Inc

    • Figure Sales and Growth Rate Analysis of Morphotek Inc

    • Figure Revenue and Market Share Analysis of Morphotek Inc

    • Table Product and Service Introduction of Morphotek Inc

    • Table Company Profile and Development Status of Amgen Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen Inc

    • Figure Sales and Growth Rate Analysis of Amgen Inc

    • Figure Revenue and Market Share Analysis of Amgen Inc

    • Table Product and Service Introduction of Amgen Inc

    • Table Company Profile and Development Status of GlaxoSmithKline Plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline Plc

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline Plc

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline Plc

    • Table Product and Service Introduction of GlaxoSmithKline Plc

    • Table Company Profile and Development Status of Takeda Pharmaceutical Co Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceutical Co Ltd

    • Figure Sales and Growth Rate Analysis of Takeda Pharmaceutical Co Ltd

    • Figure Revenue and Market Share Analysis of Takeda Pharmaceutical Co Ltd

    • Table Product and Service Introduction of Takeda Pharmaceutical Co Ltd


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.